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Abstract
Studies have suggested that vitamin D status at birth may be associated with a range of neonatal outcomes. The aim of this study was to assess
the association between neonatal 25-hydroxyvitamin D3 (25(OH)D3) concentration and gestational age, birth weight, Ponderal Index and size
for gestational age. Neonatal capillary blood stored as dried blood spots was used to assess 25(OH)D3 concentrations among 2686 subjects
selected from a random population sub-sample of individuals, born in Denmark from 1 May 1981 to 31 December 2002. There was an inverse
association between 25(OH)D3 concentration and gestational age at birth of −0·006 (95% CI −0·009, −0·003, P< 0·001) weeks of gestation per
1 nmol/l increase in 25(OH)D3 concentration. An inverted U-shaped association between 25(OH)D3 and birth weight and Ponderal Index
(P= 0·04) was found, but no association with size for gestational age was shown. This study suggests that neonatal 25(OH)D3 concentration is
associated with anthropometric measures at birth known to be correlated with many subsequent health outcomes such as obesity and type 2
diabetes.
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Nutritional factors during pregnancy inﬂuence fetal growth
and neonatal outcomes. Furthermore, neonatal outcomes
such as birth weight, size for gestational age or Ponderal
Index affect perinatal morbidity, persistent short stature and
are associated with fat mass and risk of metabolic syndrome
later in life(1–4).
The fetus relies entirely on maternal vitamin D stores, and
neonatal plasma concentration of 25-hydroxyvitamin D
(25(OH)D) corresponds to 60–70% of maternal stores(5,6). As
vitamin D deﬁciency is relatively common among women of
child-bearing age, the prevalence of vitamin D deﬁciency in
newborns is also relatively high(7). Studies have shown that
women with higher vitamin D status tend to give birth to
heavier and longer babies and may be less likely to give birth to
small-for-gestational-age (SGA) infants(8,9). On the other hand,
two recent cohort studies did not ﬁnd any association between
umbilical cord blood or maternal 25(OH)D concentrations and
neonatal anthropometric measures such as birth weight and
Ponderal Index(10,11). Other studies have shown that vitamin D
deﬁciency in pregnancy was associated with an increased risk of
macrosomia and postnatal overweight(12), as well as increased fat
mass at ages 4 and 6 years(13), whereas a recent study did not ﬁnd
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; DBS, dried blood spots; DMBR, Danish medical birth register; LGA, large for gestational age; SGA, small for
gestational age.
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any association between 25(OH)D concentration at birth and the
risk of overweight at the age of 7 years(14).
Recent reviews and meta-analyses on the association
between 25(OH)D during pregnancy and neonatal outcomes
highlight heterogeneity between studies and conﬂicting
results(15,16). In addition, most previous studies assessed
25(OH)D status in maternal blood during pregnancy, and a few
have used measurements of cord blood 25(OH)D at delivery in
relation to neonatal outcomes(6,17–21). No previous study has
used newborns’ 25(OH)D measurements of capillary blood
from dried blood spots (DBS) to study the relation between
vitamin D stores and neonate anthropometric outcomes. We
had the opportunity to access comprehensive registers in
combination with systematically collected biological material
from neonates, which offered the possibility to study such
associations in Denmark.
The aim of this study was therefore to examine the associa-
tions between neonatal 25(OH)D3 concentration measured
from DBS and gestational age at birth, birth weight, Ponderal
Index and size for gestational age among a large random
sample of neonates born in Denmark.
Methods
Population
Using the Danish Personal Civil Registration (CPR) numbers, a
random sample of 2865 individuals born in Denmark from 1
May 1981 to 31 December 2002 was selected from the Danish
Civil Registration System. In addition, using the CPR numbers,
individuals in the sub-cohort were linked to the Biological
Specimen Bank for Neonatal Screening at Statens Serum Institut
(SSI) for retrieval of DBS.
The initial criteria for being included in the study were that
the individuals were required to be born in Denmark, and
have accessible and sufﬁcient biological material available from
the DBS for the vitamin D analyses. Children from multiple
pregnancies were included.
A ﬂow chart of the selection of the included subjects is
presented in Fig. 1.
Neonatal vitamin D measures
In Denmark, every newborn undergoes heel-prick collection of
capillary blood stored on ﬁlter paper (DBS card) in connection
with a routine screening for congenital disease within 5–7 d
after birth until 2009 and within 48–72 h after birth thereafter.
The remaining blood on the DSB cards is then stored at the
Biological Specimen Bank for Neonatal Screening at the SSI(22)
at −20°C in a locked freezer. The concentrations of 25(OH)D2
and 25(OH)D3 were assessed from one 3·2-mm punch, taken
half-way from the centre in the residual of the DBS card.
Regardless of temperature and light exposure, storage times of
the DBS cards for more than 20 years are not expected to bias
inter-individual variation in concentrations(23).
The sample preparation and assays were performed by the
SSI using a highly sensitive liquid chromatography tandem mass
spectroscopy assay(23). The CV% for intra-assay and inter-assay
variation for 25(OH)D2 ranged from 4 to 8% and 9 to 18%,
respectively. For 25(OH)D3, the intra-assay and inter-assay CV%
ranged from 7 to 12% and 7 to 20%, respectively, which is
considered an acceptable precision for intra-assay and inter-
assay analyses(23). Laboratory investigators were blinded to
the season of birth, as well as the outcome measurements.
Currently no quality-assurance programmes for 25(OH)D
measures in DBS were found, but the SSI laboratory participates
in the Vitamin D External Quality Assessment Scheme with the
equivalent-serum method(24).
The majority (91%) of 25(OH)D2 concentrations were below
the detection limit of 3 nmol/l, which led us to omit these
analyses, and consequently only the concentrations of 25(OH)D3
(detection limit of 4 nmol/l) are reported here. These results are
probably owing to the very few natural dietary sources for vitamin
25(OH)D2 and the fact that in Denmark vitamin 25(OH)D2 sup-
plements are not recommended (25(OH)D3 supplements are
recommended). To approximate sera values, the 25(OH)D3
concentrations have been corrected using an algorithm that takes
into account the neonatal haematocrit (HCt) fraction for capillary
blood: serum 25(OH)D3 (nmol/l)=DBS 25(OH)D3 (nmol/l)×1/
(1−0·61 (HCt fraction))(23,25). Serum 25(OH)D3 concentration
was expressed in nmol/l and used as a continuous variable.
Anthropometric variables
Information from each individual on gestational age and
anthropometric measures at birth was retrieved from the Danish
Medical Birth Register (DMBR) maintained by Denmark Statis-
tics. Gestational age at birth was based on gestational weeks.
Birth weight in grams was used.
Owing to possible multicollinearity between birth weight and
length, the Ponderal Index was used as an indicator of fetal
growth. The Ponderal Index compares birth weight with length
and is an assessment of fetal growth. To calculate Ponderal
Index, the following formula was used: ((body weight in
grams× 100)/(birth length in cm3)). The mean Ponderal Index
among term infants is usually about 2·5 g× 100/cm3(26,27).
Another clinically relevant assessment of fetal growth is the
use of categories of size for gestational age at birth, which,
unlike birth weight that is independent of gestational age,
provide additional information about fetal growth adjusted for
sex and gestational age at birth using population references. To
classify infant size in relation to gestational age, at ﬁrst, the
relevant International Fetal and Newborn Growth Consortium
for the 21st Century (INTERGROWTH-21) references were
considered to be used. However, they were found to largely
overestimate the number of infants born large for gestational
age (LGA) in our data; hence, Danish references were pre-
ferred(28,29). Those below the 10th percentile were considered
SGA infants, and those above the 90th percentile of birth weight
were considered LGA infants, adjusted for sex-speciﬁc gesta-
tional age using Danish references(29).
Covariates
The DMBR includes information on maternal demographics and
pregnancy characteristics such as maternal place of origin,
maternal smoking status during pregnancy, maternal age,
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maternal education and parity. Maternal place of origin was
dichotomised into European v. Non-European (according to
maternal place of birth). Manual data collection regarding
maternal smoking during pregnancy started in 1991, and
women were categorised as either smoking or non-smoking
during pregnancy. Since 1997, data were collected electro-
nically and further categories were added: unknown, mother
not smoking, mother smokes, mother stopped smoking in the
ﬁrst trimester, mother stopped smoking after the ﬁrst trimester
and mother smokes up to 5, 6–10, 11–20 or >20 cigarettes/d.
Combining this information, maternal smoking was categorised
into ever smoking (women who ever smoked during their
pregnancy), never-smoking (women who never smoked during
their pregnancy) or unknown. Maternal age at time of delivery
was used as a continuous variable. Maternal education was
categorised into Primary school, High school and University
based on the highest education achievement level. On the basis
of date of birth of the children, we deﬁned season of birth
as follows: Winter-born, between November and January;
Spring-born, between February and April; Summer-born,
between May and July; and Autumn-born, between August and
October. Categorisation was based on the seasonal variation in
serum 25(OH)D concentration among individuals from coun-
tries in northern latitudes(30,31). The reporting of parity changed
during the study period. From 1973 to 1996, the DMBR only
included information on live and still births, and to estimate
parity we used the summarised estimates of total births and the
actual birth. From 1996, parity was dichotomised into primi-
parous and multiparous.
Statistics
Analyses were restricted to children born at term, deﬁned as
between 37 and 44 weeks of gestation.
Restricted cubic spline regression models and likelihood ratio
tests were used to assess possibility of non-linear associations
between 25(OH)D3 and gestational age at birth, birth weight and
Ponderal Index. Multinomial regression analyses were used to
assess the associations between neonatal 25(OH)D3 and cate-
gories of size for gestational age (SGA and LGA). All regression
models were adjusted for maternal place of origin, maternal
smoking, maternal age, maternal education, year of birth and
season of birth based on theoretical and biological plausibility.
Sensitivity analyses deﬁning gestational age based on gestational
week −1 were run, as data on gestational age in the DMBR were
previously found to be overestimated by 1 week (systematic
error) compared with medical records(32). The associations
between parity and neonatal vitamin D, gestational age at birth,
birth weight and Ponderal Index is not yet well established.
However, parity could potentially be a confounder; hence, sen-
sitivity analyses adding parity to the model were performed.
The analyses and the graphics were produced using the
statistical software package Stata 13 (2013, StataCorp LP; www.
stata.com). Bases for the splines were computed by the
‘mkspline’ command. All splines had three knots, and the loca-
tions of the knots were at the 10th (concentration: 7·6nmol/l),
50th (concentration: 23·7nmol/l) and 90th (concentration:
51·8nmol/l) percentiles of 25(OH)D3.
The signiﬁcance level for all tests was set at 0·05.
The Danish National Committee on Biomedical Research
Ethics Permission, as well as the steering committee from the
biobank, gave permission to access and analyse the DBS
samples from the Biological Specimen Bank for Neonatal
Screening (J. no. H-3-2011-126). Permission from the Danish
Data Protection Agency to merge biobank information with the
information from the registers was granted (J. no.: 2012-41-116).
This study is part of the D-tect project, which is registered on
clinicaltrials.gov: NCT03330301
Results
Vitamin D (25(OH)D3) measurements were available for a total
of 2873 newborns. After exclusion of individuals born preterm,
2686 25(OH)D3 measurements were available (Fig. 1). The
mean concentration of 25(OH)D3 was 27·2 (SD 18·3) nmol/l
(ranging from 0·4 to 110 nmol/l).
The baseline characteristics of the study population are pre-
sented in Table 1.
All individuals born in Denmark
during 1981–2002 from the Danish
Civil registration system
1360 466
Random subcohort of individuals
born during 1981–2002 sampled
for analyses and delivered to Statens
Serum Institute to find dried blood
spot cards
3585
Excluded due to unavailable
vitamin D analysis result*: 712
Individuals with vitamin D results
2873
Excluded due to preterm birth: 128
Individuals with vitamin D results
included in the descriptive
analyses
2686
Excluded due to unavailable
data on birth weight: 10
or birth length: 32
Individuals with vitamin D results
included in analyses for:
Birth weight: 2676
Ponderal Index: 2654
Fig. 1. Flow chart of the study population. *Dried blood spot cards were either
not found, there was insufficient material for analysis or the analysis failed.
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25-hydroxyvitamin D3 and gestational age at birth
The mean gestational age at birth was 39·8 (SD 1·3) weeks,
ranging from 37 to 44 (n 2686).
Assessment of the ﬁtted spline (Fig. 2) suggested an inverse
linear association between 25(OH)D3 and gestational age at
birth, which was conﬁrmed by the statistical tests. The likelihood
ratio test of an overall association indicated that the null
hypothesis (the model including 25(OH)D3 is not better than the
null model) could be rejected (P= 0·003), and the likelihood ratio
test of non-linearity indicated that the spline regression model did
not ﬁt the data better than the linear one (P= 0·71). The linear
model resulted in an inverse association between 25(OH)D3
concentration and gestational age at birth, with a decrease of
0·006 (95% CI− 0·009, −0·003, P< 0·001) weeks of gestation per
1 nmol/l increase in 25(OH)D3 concentration (Table 2).
25-Hydroxyvitamin D3 and birth weight
The mean birth weight was 3532 (SD 507) g (n 2676). Boys had a
higher mean birth weight than girls, 3612 (SD 512) g and 3448
(SD 487) g, respectively (P< 0·001). Assessment of the ﬁtted
spline (Fig. 3) showed an inverted U-shaped association
between 25(OH)D3 and birth weight, which was conﬁrmed by
the statistical tests. The likelihood ratio test of an overall asso-
ciation indicated that the null hypothesis could be rejected
(P= 0·04) and the likelihood ratio test of non-linearity indicated
that the spline regression model ﬁtted the data better than the
linear one (P= 0·01).
25-Hydroxyvitamin D3 and Ponderal Index
The mean Ponderal Index was 2·5 g× 100/cm3 (SD 0·3),
ranging from 1·8 to 3·5 g× 100/cm3 (n 2654). Assessment of the
Table 1. Maternal and offspring characteristics
(Mean values and standard deviations; numbers and percentages)
Continuous variables n Mean SD
Neonatal 25(OH)D3 (nmol/l) 2686 27·2 18·3
Gestational age at birth (weeks) 2686 39·8 1·3
Birth weight (g) 2676 3532 506·9
Ponderal Index (g × 100/cm3) 2654 2·5 0·3
Maternal age (years) 2686 28·3 4·8
Categorical variables n %
Size for gestational age
AGA 2046 77·0
SGA 330 12·4
LGA 280 10·5
Offspring sex
Male 1381 51·4
Female 1305 48·6
Maternal place of origin
European 2497 93·0
Non-European 189 7·0
Maternal smoking
Smoker 369 13·7
Non-smoker 1137 42·3
Unknown 1180 43·9
Maternal education
Primary School 798 29·7
High school 1240 46·2
University 564 21·0
Unknown 84 3·1
Season of birth
Winter 630 23·5
Spring 647 25·1
Summer 680 25·3
Autumn 702 26·1
Years of birth
1981–1990 1092 40·7
1991–2002 1594 59·3
AGA, appropriate for gestational age; SGA, small for gestational age; LGA, large for
gestational age.
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Fig. 2. Spline 25-hydroxyvitamin D3 (25(OH)D3) concentration (nmol/l) and
gestational age (weeks) at birth after mutual adjustment for maternal place of
origin, smoking, age, education, season and year of birth among a random
sample of infants born at term (weeks 37–44) in the years between 1981 and
2002 in Denmark (n 2686).
Table 2. Multivariate linear regression analyses of the association between
25-hydroxyvitamin D3 (25(OH)D3) concentration (nmol/l) and gestational
age at birth in weeks among a random sample of infants born at term
(weeks 37–44) in the years between 1981 and 2002 in Denmark (n 2686)*
(Coefficients with their standard errors and 95% confidence intervals)
Gestational age at birth Coefficient SE 95% CI P
25(OH)D3 (nmol/l)
(continuous)
−0·006 0·002 −0·009, −0·003 <0·001
Maternal education
School Ref.
Unknown 0·08 0·15 −0·22, 0·38 0·62
High school 0·15 0·06 0·03, 0·27 0·01
University 0·22 0·01 0·07, 0·37 0·004
Maternal age (years)
(continuous)
−0·01 0·01 −0·02, 0·01 0·30
Maternal smoking
Smoking Ref.
Unknown −0·09 0·10 −0·29, 0·10 0·35
Non-smoking 0·01 0·08 −0·14, 0·17 0·86
Maternal place of origin
European Ref.
Non-European −0·17 0·11 −0·38, 0·04 0·11
Season
Winter Ref.
Spring 0·14 0·07 −0·002, 0·28 0·05
Summer 0·23 0·07 0·09, 0·37 0·002
Autumn 0·22 0·07 0·08, 0·36 0·003
Year of birth (continuous) −0·02 0·01 −0·03, −0·001 0·04
Ref., referent values.
* Analyses were performed after mutual adjustment for maternal place of origin,
smoking, age, education, season and year of birth.
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ﬁtted spline (Fig. 4) shows an inverted U-shaped association
between 25(OH)D3 and Ponderal Index, which was conﬁrmed
by the statistical tests. The likelihood ratio test of an overall
association indicated that the null hypothesis could be rejected
(P= 0·04) and the likelihood test of non-linearity indicated
that the spline regression model ﬁtted the data better than the
linear one (P= 0·01).
25-Hydroxyvitamin D3 and size for gestational age
Most infants were adequate for gestational age (AGA) (n 2046),
330 were SGA (12%) and 280 were LGA (11%). 25(OH)D3
concentrations differed between SGA (26·2 (SD 17·9)), AGA
(27·2 (SD 18·5)) and LGA (29·2 (SD 17·9)) infants. However, the
results from the multinomial regression analyses showed that
the relative risk ratio of being SGA or LGA compared with AGA
was not associated with 25(OH)D3 concentration (P= 0·6)
(Table 3).
Results from sensitivity analyses deﬁning gestational age
based on gestational week −1, and from including parity as a
confounder, were essentially similar (online Supplementary
Material).
Discussion
Using a large and randomly selected population-based sample
of infants born in Denmark, we found that neonatal 25(OH)D3
concentration was signiﬁcantly associated with gestational age
at birth, birth weight and Ponderal Index, but not associated
with size for gestational age. Notably, our analyses were
restricted to infants born at term, as the underlying causes of
preterm births such as infections, diabetes, high blood pressure,
stress or nutritional status may inﬂuence maternal and fetal
pregnancy outcomes and vitamin D concentrations(33).
Gestational age
Our results suggested an inverse linear association between
fetal 25(OH)D3 and gestational age, indicating that lower vita-
min D does not seem to be related to a suspension of gestation
in babies born at term. Our ﬁndings are supported by results
from previous studies. For instance, Hossain et al.(34) found
higher vitamin D concentrations from cord blood among
Pakistani neonates born before 37 weeks of gestation than
among neonates born at later gestation. In addition, the authors
reported a decrease in maternal serum concentrations of
25(OH)D with longer duration of gestation. Another long-
itudinal study among 141 Danish women reported that
25(OH)D concentration increased between weeks 18 and 32
and decreased from 32 to 8 weeks postpartum among healthy
pregnant women(35). As maternal and fetal 25(OH)D con-
centrations are correlated(5,6), it is likely that both maternal and
fetal vitamin D concentrations ﬂuctuate by gestational weeks
following a similar pattern. Decreasing concentrations of
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Fig. 4. Spline 25-hydroxyvitamin D3 (25(OH)D3) (nmol/l) and Ponderal Index
(g × 100/cm3) after mutual adjustment for maternal place of origin, smoking,
age, education, season and year of birth among a random sample of
infants born at term (weeks 37–44) in the years between 1981 and 2002 in
Denmark (n 2654).
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Fig. 3. Spline of 25-hydroxyvitamin D3 (25(OH)D3) (nmol/l) and birth weight (g)
after mutual adjustment for maternal place of origin, smoking, age, education,
season and year of birth among a random sample of infants born at term
(weeks 37–44) in the years between 1981 and 2002 in Denmark (n 2676).
Table 3. Multinomial regression analyses of 25-hydroxyvitamin D3 (25(OH)D3) concentration (nmol/l) and size for gestational age
among a random sample of infants born at term (weeks 37–44) in the years between 1981 and 2002 in Denmark (n 2656)
(Relative risk ratios (RRR) with their standard errors and 95% confidence intervals)
Crude model Adjusted model*
Categories of birth weight RRR SE 95% CI P RRR SE 95% CI P
SGA 1·00 0·003 0·99, 1·00 0·38 1·00 0·004 0·99, 1·01 0·60
AGA Ref. Ref.
LGA 1·01 0·003 1·00, 1·01 0·08 1·00 0·004 1·00, 1·01 0·55
SGA, small for gestational age; AGA, appropriate for gestational age; Ref., referent value; LGA, large for gestational age.
* Adjusted for maternal place of origin, smoking, age, education, season and year of birth.
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neonatal vitamin D with longer duration of gestation might be
explained by a decreasing efﬁciency of the decidua to transfer
25(OH)D3 from the mother to the fetus. This ﬂuctuation might
also be owing to maternal physiological variation in vitamin D
concentrations during pregnancy, because of changes in mater-
nal plasma vitamin D binding protein and variations in intestinal
absorption of vitamin D(34–36). In addition, the concentration
of the active form of vitamin D (1,25-dihydroxycholecalciferol
(1,25(OH)D)) increases during gestation(37), and as 25(OH)D has
a shorter half-life when 1,25(OH)D concentration increases,
25(OH)D concentration tends to decrease. However, the aetiol-
ogy behind the changes in 25(OH)D during pregnancy remains
controversial(38). Furthermore, in late gestation, mothers seem to
have less outdoor activities and therefore potentially less skin
synthesis of vitamin D through sun exposure(39).
The association between 25(OH)D and gestational age at
birth might be bidirectional. Indeed, higher neonatal 25(OH)D
concentrations may shorten gestational length among infants
born at term, but longer gestational length may also lower
neonatal 25(OH)D concentrations. In the present study,
establishing a causal pathway was not possible.
Further basic studies on maternal–fetal vitamin D variations and
placental transfer at different stages of gestation are needed to
clarify the underlying mechanisms involved, as they still remain
unclear(40). However, at present, the restricted possibility to
access direct information on vitamin D status of the human fetus
limits our possibility for understanding fetal physiology(41).
Birth weight and Ponderal Index
A signiﬁcant non-linear association was found between neonatal
25(OH)D3 and birth weight, as well as between neonatal
25(OH)D3 and Ponderal Index. These results are in accordance
with results from a study including 1491 Chinese neonates, also
ﬁnding an inverted U-shaped association between 25(OH)D from
cord blood and birth weight(21) and another study from the USA
ﬁnding a non-linear association between maternal 25(OH)D and
birth weight(8), thus suggesting that higher vitamin D concentra-
tions do not seem to beneﬁt fetal growth, or may have dual
biological effects on fetal growth(21). However, contrary to our
ﬁndings, as well as to those of Zhu et al. and Gernand et al., Shor
et al. and Eggemoen et al. did not ﬁnd an association between
maternal vitamin D and birth weight. However, in these two latter
studies, analyses were limited to using linear models(8,21,42,43).
Furthermore, another Danish study(44) found a U-shaped asso-
ciation between cord 25(OH)D and birth weight. Multiple causes
might explain the inconsistent ﬁndings, such as difference in birth
period (1981–2002 v. 2010–2012), possible lifestyle changes
between 1981 and 2012, sample selection (representative sample
v. healthy women), 25(OH)D concentrations (27·2 (SD 18·3) v.
47·0 (SD 21·7) nmol/l) and methodological differences (DBS v.
cord blood; adjustment for different confounders; residual con-
founding). In regard to Ponderal Index, no associations were
found in the studies by Eggemoen et al. and Gernand et al.(8,43).
These discrepancies might be owing to different study designs,
analytic methods and lack of power, but may also relate
to the relative difﬁculty of measuring the crown–heel length of
newborns. As cubic length is used to calculate Ponderal Index,
even small measurement errors can have substantial inﬂuence on
the accuracy of the Ponderal Index(45).
Size for gestational age
There was no association between 25(OH)D3 and the cate-
gories of size for gestational age. These results are consistent
with our ﬁndings of an inverted U-shaped association between
25(OH)D3 and birth weight, which indicates that vitamin D
effects on fetal growth might be dual. Conﬂicting ﬁndings
on this association are, however, present in the literature.
Narrative and systematic reviews and meta-analyses indicate
that an association between 25(OH)D and the risk of SGA
from observational studies exist, but not from randomised
trials(20,46–48). The discrepant results might be owing to differ-
ences in study designs, exposure and/or outcome deﬁnitions
and measurements, as well as study populations.
Strengths and limitations
The strengths of this study lie in the large sample of individuals
randomly selected among the entire Danish population with
neonatal biological measurements of 25(OH)D3 from DBS, as
well as the use of the high-quality register data from the DMBR,
where demographic data, birth weight and parity have shown
good precision compared with medical records(32). Data on
gestational age in DMBR, compared with medical records, were
found to overestimate actual gestational age by 1 week(32), and
to account for this, sensitivity analyses were run. In addition,
another strength of this study is that multinomial and spline
regression analyses with adjustment for a large number of
confounders, including year of birth to account for secular
changes in birth weight in Denmark between 1981 and 2002(49),
were performed. The study has also limitations. First, measures
of 25(OH)D, birth weight and gestational age were collected
within 7 d after birth; hence, a cause–effect direction could not
be established. Second, information on maternal vitamin D
concentrations, breast-feeding, maternal weight or BMI, out-
door activity and dietary intake were not available; hence, they
could not be included as covariates in our statistical models.
Third, adjustment for smoking during pregnancy might not be
comprehensive, as information about maternal smoking status
was missing for more than 40% of individuals and reporting
bias may have occurred. The current results might only be
generalised to populations with similar characteristics as the
Danish population.
Conclusion
Overall, this large study conducted in a random subset of the
Danish population suggests that neonatal 25(OH)D3 con-
centration is inversely associated with gestational age at birth;
the later the gestational age, the lower the concentrations. In
addition, our results suggest that neonatal 25(OH)D3 con-
centration has an inverted U-shaped association with birth
weight and Ponderal Index, which are known to be correlated
with many subsequent health outcomes such as obesity and
type 2 diabetes, and is not associated with size for gestational
age (SGA and LGA).
Vitamin D and anthropometric outcomes 1421
https://doi.org/10.1017/S0007114518000879
Downloaded from https://www.cambridge.org/core. UQ Library, on 02 Aug 2018 at 02:45:46, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
Randomised clinical trials are needed to draw ﬁrm conclu-
sions regarding the causal direction of the associations found.
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